Senior insider sale
Chief Medical Officer at MAPLIGHT THERAPEUTICS, INC. — senior position signals high conviction
$3.47M
106.09K shares
FOFF ERIN PENNOCK plans to sell 106.09K shares of MAPLIGHT THERAPEUTICS, INC. valued at approximately $3.47M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/18/2025 | Restricted Stock Unit Grant N/A | 60.35K | — |
5/2/2024 | Restricted Stock Unit Grant N/A | 6.35K | — |
11/9/2023 | Restricted Stock Unit Grant N/A | 1.55K | — |
7/30/2023 | Restricted Stock Unit Grant N/A | 3.35K | — |
| Total | 71.59K | ||
Completed
Units to sell
4.44K
Market value
$126.6K
Units to sell
24.05K
Market value
$691.8K
Units to sell
10.58K
Market value
$298.2K
Units to sell
15.65K
Market value
$437.6K
Units to sell
1.17K
Market value
$32.0K
Units to sell
2.04K
Market value
$54.9K
Planned — Approximate Date
Units to sell
48.16K
Market value
$1.83M
Units
106.09K
Value
$3.47M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/7/2026 | 4.44K | $126.6K | — | Completed |
5/6/2026 | 24.05K | $691.8K | — | Completed |
5/5/2026 | 10.58K | $298.2K | — | Completed |
5/4/2026 | 15.65K | $437.6K | — | Completed |
4/16/2026 | 1.17K | $32.0K | — | Completed |
4/15/2026 | 2.04K | $54.9K | — | Completed |
| Planned — Approximate Date | ||||
7/15/2026 | 48.16K | $1.83M | NASDAQ | Planned |
| Total | 106.09K | $3.47M | ||